GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » NonCurrent Deferred Liabilities

Biotest AG (XTER:BIO3) NonCurrent Deferred Liabilities : €0.0 Mil (As of Dec. 2024)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Biotest AG's non-current deferred liabilities for the quarter that ended in Dec. 2024 was €0.0 Mil.

Biotest AG NonCurrent Deferred Liabilities Historical Data

The historical data trend for Biotest AG's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG NonCurrent Deferred Liabilities Chart

Biotest AG Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biotest AG Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biotest AG NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Biotest AG's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » NonCurrent Deferred Liabilities
Comparable Companies
XTER:FYB XTER:HPHA STU:T9G XTER:MDG1 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN
Traded in Other Exchanges
BTTAY:USA BIESF:USA 0N70:UK BIO3:Austria
Address
Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303
Website
https://www.biotest.com
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.
Executives
Dr. Katrin Bernöster Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke Senior Vice President plasma alliances and proteine supply
Stephan Fleck Vice President Corporate Controlling
Dr. Jörg Schüttrumpf VP Corp. Research &Development
Michael Moritz VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines